Gajić, Snežana

Link to this page

Authority KeyName Variants
9b19458e-b953-4042-ba66-fc2c9caf3892
  • Gajić, Snežana (2)
Projects

Author's Bibliography

Evaluation of Renal Damage by Urinary Beta-Trace Protein in Patients with Chronic Kidney Disease

Dajak, Marijana; Ignjatović, Svetlana; Stojimirović, Biljana; Gajić, Snežana; Majkić-Singh, Nada

(Clin Lab Publ, Heidelberg, 2011)

TY  - JOUR
AU  - Dajak, Marijana
AU  - Ignjatović, Svetlana
AU  - Stojimirović, Biljana
AU  - Gajić, Snežana
AU  - Majkić-Singh, Nada
PY  - 2011
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1499
AB  - Background: Beta-trace protein (BTP) was found to be increased in the serum and urine of patients with renal diseases. The aim of this study was to compare the urinary levels of beta-trace protein with levels of other urinary proteins: albumin, beta(2)-microglobulin (B2M), alpha(1)-microglobulin (A1M), and cystatin C and to determine its clinical usefulness for detection of renal dysfunction in chronic kidney disease (CKD). Methods: These markers were measured in 24-hour urine samples from 134 patients with CKD. Results: BTP correlated significantly with A1M (r = 0.871), cystatin C (r = 0.759), total protein (r = 0.684), B2M (r = 0.497), and albumin (r = 0.448) in 24-hour urine samples (P  lt  0.05). Urinary BTP concentrations in patients with albuminuria below 30 mg / day were significantly lower than in patients with albuminuria above 30 mg / day (P  lt  0.0001). ROC analysis showed high diagnostic accuracy of BTP for detection of > 30 mg / day albuminuria (AUC 0.908). Urinary BTP was also in significant correlation with the estimated glomerular filtration rate (r = -0.580). Conclusions: The results of our study suggest that BTP may be a useful and reliable urinary marker of renal dysfunction and may have a place in addition to urinary alpha(1)-microglobulin and albumin as an alternative marker for tubular damage and the magnitude of renal impairment in patients with chronic kidney disease. (Clin. Lab. 2011;57:29-36)
PB  - Clin Lab Publ, Heidelberg
T2  - Clinical Laboratory
T1  - Evaluation of Renal Damage by Urinary Beta-Trace Protein in Patients with Chronic Kidney Disease
VL  - 57
IS  - 1-2
SP  - 29
EP  - 36
UR  - https://hdl.handle.net/21.15107/rcub_farfar_1499
ER  - 
@article{
author = "Dajak, Marijana and Ignjatović, Svetlana and Stojimirović, Biljana and Gajić, Snežana and Majkić-Singh, Nada",
year = "2011",
abstract = "Background: Beta-trace protein (BTP) was found to be increased in the serum and urine of patients with renal diseases. The aim of this study was to compare the urinary levels of beta-trace protein with levels of other urinary proteins: albumin, beta(2)-microglobulin (B2M), alpha(1)-microglobulin (A1M), and cystatin C and to determine its clinical usefulness for detection of renal dysfunction in chronic kidney disease (CKD). Methods: These markers were measured in 24-hour urine samples from 134 patients with CKD. Results: BTP correlated significantly with A1M (r = 0.871), cystatin C (r = 0.759), total protein (r = 0.684), B2M (r = 0.497), and albumin (r = 0.448) in 24-hour urine samples (P  lt  0.05). Urinary BTP concentrations in patients with albuminuria below 30 mg / day were significantly lower than in patients with albuminuria above 30 mg / day (P  lt  0.0001). ROC analysis showed high diagnostic accuracy of BTP for detection of > 30 mg / day albuminuria (AUC 0.908). Urinary BTP was also in significant correlation with the estimated glomerular filtration rate (r = -0.580). Conclusions: The results of our study suggest that BTP may be a useful and reliable urinary marker of renal dysfunction and may have a place in addition to urinary alpha(1)-microglobulin and albumin as an alternative marker for tubular damage and the magnitude of renal impairment in patients with chronic kidney disease. (Clin. Lab. 2011;57:29-36)",
publisher = "Clin Lab Publ, Heidelberg",
journal = "Clinical Laboratory",
title = "Evaluation of Renal Damage by Urinary Beta-Trace Protein in Patients with Chronic Kidney Disease",
volume = "57",
number = "1-2",
pages = "29-36",
url = "https://hdl.handle.net/21.15107/rcub_farfar_1499"
}
Dajak, M., Ignjatović, S., Stojimirović, B., Gajić, S.,& Majkić-Singh, N.. (2011). Evaluation of Renal Damage by Urinary Beta-Trace Protein in Patients with Chronic Kidney Disease. in Clinical Laboratory
Clin Lab Publ, Heidelberg., 57(1-2), 29-36.
https://hdl.handle.net/21.15107/rcub_farfar_1499
Dajak M, Ignjatović S, Stojimirović B, Gajić S, Majkić-Singh N. Evaluation of Renal Damage by Urinary Beta-Trace Protein in Patients with Chronic Kidney Disease. in Clinical Laboratory. 2011;57(1-2):29-36.
https://hdl.handle.net/21.15107/rcub_farfar_1499 .
Dajak, Marijana, Ignjatović, Svetlana, Stojimirović, Biljana, Gajić, Snežana, Majkić-Singh, Nada, "Evaluation of Renal Damage by Urinary Beta-Trace Protein in Patients with Chronic Kidney Disease" in Clinical Laboratory, 57, no. 1-2 (2011):29-36,
https://hdl.handle.net/21.15107/rcub_farfar_1499 .
7

Urinary beta-trace protein as a tubular marker of renal dysfunction in patients with chronic kidney disease

Dajak, Marijana; Ignjatović, Svetlana; Stojimirović, Biljana; Gajić, Snežana; Majkić-Singh, Nada

(Elsevier Science BV, Amsterdam, 2010)

TY  - JOUR
AU  - Dajak, Marijana
AU  - Ignjatović, Svetlana
AU  - Stojimirović, Biljana
AU  - Gajić, Snežana
AU  - Majkić-Singh, Nada
PY  - 2010
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1400
PB  - Elsevier Science BV, Amsterdam
T2  - Clinica Chimica Acta
T1  - Urinary beta-trace protein as a tubular marker of renal dysfunction in patients with chronic kidney disease
VL  - 411
IS  - 15-16
SP  - 1154
EP  - 1155
DO  - 10.1016/j.cca.2010.04.013
ER  - 
@article{
author = "Dajak, Marijana and Ignjatović, Svetlana and Stojimirović, Biljana and Gajić, Snežana and Majkić-Singh, Nada",
year = "2010",
publisher = "Elsevier Science BV, Amsterdam",
journal = "Clinica Chimica Acta",
title = "Urinary beta-trace protein as a tubular marker of renal dysfunction in patients with chronic kidney disease",
volume = "411",
number = "15-16",
pages = "1154-1155",
doi = "10.1016/j.cca.2010.04.013"
}
Dajak, M., Ignjatović, S., Stojimirović, B., Gajić, S.,& Majkić-Singh, N.. (2010). Urinary beta-trace protein as a tubular marker of renal dysfunction in patients with chronic kidney disease. in Clinica Chimica Acta
Elsevier Science BV, Amsterdam., 411(15-16), 1154-1155.
https://doi.org/10.1016/j.cca.2010.04.013
Dajak M, Ignjatović S, Stojimirović B, Gajić S, Majkić-Singh N. Urinary beta-trace protein as a tubular marker of renal dysfunction in patients with chronic kidney disease. in Clinica Chimica Acta. 2010;411(15-16):1154-1155.
doi:10.1016/j.cca.2010.04.013 .
Dajak, Marijana, Ignjatović, Svetlana, Stojimirović, Biljana, Gajić, Snežana, Majkić-Singh, Nada, "Urinary beta-trace protein as a tubular marker of renal dysfunction in patients with chronic kidney disease" in Clinica Chimica Acta, 411, no. 15-16 (2010):1154-1155,
https://doi.org/10.1016/j.cca.2010.04.013 . .
8
9
10